SBCM
ARRY

Silver Bridge Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Silver Bridge Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,000
Closed -$45K – 206
2013
Q2 		$45K Buy
+10,000
New +$53.8K 0.01% 241

Other funds holding ARRY

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Silver Bridge Capital Management's ARRY Position: Q3 2013 in Review

Silver Bridge Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2013, closing a stake of 10,000 shares — an estimated $45K sold.

Silver Bridge Capital Management first reported a position in ARRY in Q2 2013 and held it in 1 quarter. The position peaked at $45K in Q2 2013. 134 funds tracked by Wall St. Rank hold ARRY as of Q3 2013.

  • Silver Bridge Capital Management reported no remaining Array Biopharma Inc position as of Q3 2013 after selling out during the quarter.
  • Silver Bridge Capital Management sold 10,000 Array Biopharma Inc shares in Q3 2013, an estimated $45K.
  • Silver Bridge Capital Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 1 quarter.
  • Silver Bridge Capital Management's Array Biopharma Inc position peaked at $45K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2013.

Based on Silver Bridge Capital Management's 13F filing for Q3 2013.